Dolsten Mikael bought RCKT
June 18, 2025 · Form 4 insider transaction
Dolsten Mikael bought 30,000 shares of Rocket Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 30 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$0.00
Total value
N/A
InsiderDolsten Mikael
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 18, 2025
Filing dateJuly 18, 2025
Shares owned after44,220
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Holdings include 14,220 restricted stock units ("RSUs") that convert to common stock on a one-for-one basis held by the Reporting Person which cliff vest on December 31, 2025.; Represents RSUs that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026.